Tissue Regenix Group PLC (AIM:TRX) has appointed its chief financial officer, Kirsten Lund, to the board with immediate effect. The regenerative medical devices company, which trades on AIM, confirmed the move following Thursday’s announcement of her appointment as CFO.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com